Asthma

This association remained significant even after controlling for cigarette use and demographic characteristics.

Dupilumab shows long-term efficacy across yearly seasons in patients with type 2 inflammatory asthma.

A recent cohort study finds that prenatal opioid exposure is associated with increased risk of certain immune-related conditions, including asthma.

Asthma can be predicted using non-biological measurements from the age of 3 years, according to one study.

An artificial intelligence (AI)-aided stethoscope provides reliable information on asthma exacerbations in children, especially those under 5 years, a study suggests.

These findings support the safe use of inhaled corticosteroids (ICS) regarding the risk of pneumonia among children with asthma, according to one study.

Asthma and allergy drugs such as montelukast and cetirizine were among a list of drugs frequently implicated in major drug-drug interactions.

The study authors note that the Best Asthma Control Test for School Children and Adolescents (Best ACT-S) complements a previously developed questionnaire that assesses preschool-aged patients with asthma.

Two posters presented at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting evaluated real-world biologic utilization for patients with severe, uncontrolled asthma.

Researchers assessed care and costs incurred by people with asthma, who account for a large share of hospital admissions.

This year’s most-read asthma articles included the impact of extreme weather events, neighborhood determinants of health, and other risk factors for asthma exacerbations.

A phase 4 study found severe asthma can be controlled using biologic therapies, without the addition of high-dose inhaled steroids.

The study’s investigators suggest the results in this patient population may indicate rises in clinically diagnosed viral infections from viruses other than SARS-CoV-2 following pandemic lockdown changes.

Triple therapy may improve asthma symptoms, particularly among patients requiring systemic corticosteroids to treat severe exacerbations, a study finds.

Posters presented at ACAAI 2023 Annual Scientific Congress examined dupilumab use in children with moderate-to-severe asthma and in the presence of elevated type 2 biomarkers.

This research highlights the close relationship between pollen-induced allergic rhinitis, sensitization, and asthma.

Posters presented at ACAAI 2023 Annual Scientific Congress assessed digital health tools to improve asthma self-management.

The prevalence of eosinophilic asthma and severe asthma phenotypes was high in many countries, according to one study.

This newly developed prediction model evaluating community-acquired pneumonia risk was noted to demonstrate accuracy, strong discriminatory qualities, and practicability in clinical settings.

Reduced cost-sharing for asthma medications improved adherence to controller medications among patients with severe asthma.

Investigators hope that ongoing research and addressing disparities can improve equitable access to asthma treatments for all pediatric patients.

Social-, education-, and economic-related factors of communities may reduce childhood asthma, according to one study.

The study indicated the potential of preventative drug lists (PDLs) as a strategy for those who have high deductible health plans to address both patient access and affordability of asthma care.

A small portion of these patients with a high inhaled corticosteroid (ICS) dosage will continue use of a second medication to keep their asthma under control, according to study findings.

Not all children and teens with active asthma are achieving adequate control of their symptoms, and timely referral to secondary care is rare, according to one study.